Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease

被引:5
|
作者
Sweeney, Jacob R. [1 ]
Crawford, Carl, V [2 ]
Yantiss, Rhonda K. [3 ]
机构
[1] Cleveland Clin, Dept Pathol & Lab Med, Cleveland, OH 44106 USA
[2] Weill Cornell Med, Div Gastroenterol & Hepatol, New York, NY USA
[3] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA
关键词
infection; Crohn disease; ulcerative colitis; pseudomembranous colitis; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INFECTION; SOCIETY; UPDATE; COLECTOMY; DIARRHEA; ADULTS; RISK;
D O I
10.1111/his.14702
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims Patients with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection, although clinically important infections can be difficult to recognise. C. difficile infection does not produce pseudomembranes when it occurs in IBD patients. These individuals may also be colonised by the organism, in which case diarrhoeal symptoms are not necessarily attributed to C. difficile. We performed this study to determine whether any features distinguished C. difficile-associated colitis from an IBD flare. Methods and results We reviewed the clinical, endoscopic and biopsy findings from 50 patients with established IBD and worsening diarrhoea, including 22 with concurrent positive C. difficile stool toxin polymerase chain reaction (PCR) assays and 28 with negative C. difficile assay results. We found that C. difficile-infected patients had symptoms and endoscopic findings that were indistinguishable from active IBD. Although most biopsy samples from patients with C. difficile infection showed chronic active colitis indistinguishable from IBD, some displayed neutrophilic infiltrates unaccompanied by plasma cell-rich inflammation involving superficial (41%) and crypt (18%) epithelium as well as neutrophilic infiltrates within lamina propria distant from foci of cryptitis (32%). All three of these features were significantly more common among infected than uninfected patients (4, 0 and 4%; P = 0.002, P = 0.03 and P = 0.02, respectively). Conclusions Although colonic biopsies from IBD patients with C. difficile infection usually lack features that aid distinction from colitic flares, some cases show an acute colitis pattern not seen in IBD alone. When identified in biopsies from symptomatic IBD patients, these changes should alert pathologists to the possibility of this clinically important infection.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [21] Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
    Angela Y. Lam
    Liat S. Gutin
    Yume Nguyen
    Fernando S. Velayos
    Digestive Diseases and Sciences, 2020, 65 : 3111 - 3115
  • [22] Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
    Jakubowska, Alicja
    Szydlarska, Dorota
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (03): : 277 - 283
  • [23] Predictors of Mortality in Patients With Inflammatory Bowel Disease and Clostridioides difficile Colitis: A Retrospective Analysis From Nationwide Inpatient Sample
    Balogun, Oluwanifemi
    Echikunwoke, Blanche
    Babajide, Oyedotun
    Soladoye, Elizabeth
    Carty, Jordan
    Robinson, Kevin
    Rau, Rohan
    Olafimihan, Ayobami
    Jara-Tantoco, Mikaela Nikkola
    Lo, Kevin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S754 - S755
  • [24] Co-infection of Clostridioides Difficile Aggravates Poor Outcomes in Inflammatory Bowel Disease with Cytomegalovirus Colitis
    Hsieh, C. R.
    Le, H.
    Yeh, P. J.
    Chiu, C. T.
    Chiu, C. H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I612 - I614
  • [25] Clostridioides difficile infection in inflammatory bowel disease: a clinical review
    Tang, Mengjun
    Wang, Chunhua
    Xia, Ying
    Tang, Jian
    Wang, Jiao
    Shen, Liang
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (05) : 297 - 306
  • [26] Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
    Del Vecchio, Livio Enrico
    Fiorani, Marcello
    Tohumcu, Ege
    Bibbo, Stefano
    Porcari, Serena
    Mele, Maria Cristina
    Pizzoferrato, Marco
    Gasbarrini, Antonio
    Cammarota, Giovanni
    Ianiro, Gianluca
    MICROORGANISMS, 2022, 10 (07)
  • [27] Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection
    Voth, Elida
    Solanky, Dipesh
    Loftus, Edward V., Jr.
    Pardi, Darrell S.
    Khanna, Sahil
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [28] Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
    Abdehagh, Mohammad
    Azimirad, Masoumeh
    Houri, Hamidreza
    Nadalian, Banafsheh
    Azimirad, Fahimeh
    Olfatifar, Meysam
    Shoeibi, Ome Kolsoum Nasir
    Yadegar, Abbas
    Shahrokh, Shabnam
    Roshan, Mehran Mahdavi
    Aghdaei, Hamid Asadzadeh
    Zali, Mohammad Reza
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [29] Application of Procalcitonin for the Rapid Diagnosis of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
    Xie, Shuhua
    Chen, Peisong
    Wang, Dong
    Jiang, Xiaobing
    Wu, Zhongwen
    Liao, Kang
    Liu, Min
    Zhang, Shihong
    Chen, Yili
    DIAGNOSTICS, 2022, 12 (12)
  • [30] Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
    Mohammad Abdehagh
    Masoumeh Azimirad
    Hamidreza Houri
    Banafsheh Nadalian
    Fahimeh Azimirad
    Meysam Olfatifar
    Ome Kolsoum Nasir Shoeibi
    Abbas Yadegar
    Shabnam Shahrokh
    Mehran Mahdavi Roshan
    Hamid Asadzadeh Aghdaei
    Mohammad Reza Zali
    BMC Infectious Diseases, 21